PERSPECTA

News from every angle

← Back to headlines

Serina Therapeutics Gains NYSE Approval

Serina Therapeutics has received approval to list on the NYSE, with a compliance deadline set for 2027.

2 Apr, 21:01 — 2 Apr, 21:01
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed5d ago

Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set

Read full article →

Related Stories

Actor Rajesh Kumar Reduces Debt with Family Farming Business

13m ago

Roku Stock Experiences Seven Consecutive Sessions of Gains

14m ago

Regional Bankers Warn of Worsening Credit Stress and Economic Impact

14m ago

Fastly Leads Mid-Cap Tech Stocks in Quant Rankings Ahead of Q1 Earnings

16m ago